1. Home
  2. FUBO vs ORKA Comparison

FUBO vs ORKA Comparison

Compare FUBO & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUBO
  • ORKA
  • Stock Information
  • Founded
  • FUBO 2009
  • ORKA 2004
  • Country
  • FUBO United States
  • ORKA United States
  • Employees
  • FUBO N/A
  • ORKA N/A
  • Industry
  • FUBO Broadcasting
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • FUBO Industrials
  • ORKA Health Care
  • Exchange
  • FUBO Nasdaq
  • ORKA Nasdaq
  • Market Cap
  • FUBO 1.3B
  • ORKA 1.2B
  • IPO Year
  • FUBO 2020
  • ORKA N/A
  • Fundamental
  • Price
  • FUBO $3.85
  • ORKA $27.72
  • Analyst Decision
  • FUBO Buy
  • ORKA Strong Buy
  • Analyst Count
  • FUBO 4
  • ORKA 8
  • Target Price
  • FUBO $5.35
  • ORKA $44.38
  • AVG Volume (30 Days)
  • FUBO 20.6M
  • ORKA 426.3K
  • Earning Date
  • FUBO 11-03-2025
  • ORKA 11-11-2025
  • Dividend Yield
  • FUBO N/A
  • ORKA N/A
  • EPS Growth
  • FUBO N/A
  • ORKA N/A
  • EPS
  • FUBO 0.35
  • ORKA N/A
  • Revenue
  • FUBO $1,616,726,000.00
  • ORKA N/A
  • Revenue This Year
  • FUBO N/A
  • ORKA N/A
  • Revenue Next Year
  • FUBO $6.48
  • ORKA N/A
  • P/E Ratio
  • FUBO $10.88
  • ORKA N/A
  • Revenue Growth
  • FUBO 1.70
  • ORKA N/A
  • 52 Week Low
  • FUBO $1.21
  • ORKA $5.49
  • 52 Week High
  • FUBO $6.45
  • ORKA $29.64
  • Technical
  • Relative Strength Index (RSI)
  • FUBO 52.10
  • ORKA 62.84
  • Support Level
  • FUBO $3.23
  • ORKA $25.57
  • Resistance Level
  • FUBO $4.20
  • ORKA $29.64
  • Average True Range (ATR)
  • FUBO 0.33
  • ORKA 1.90
  • MACD
  • FUBO 0.04
  • ORKA -0.36
  • Stochastic Oscillator
  • FUBO 53.22
  • ORKA 57.51

About FUBO fuboTV Inc.

FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

Share on Social Networks: